Kähäri V M, Chen Y Q, Bashir M M, Rosenbloom J, Uitto J
Department of Dermatology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
J Biol Chem. 1992 Dec 25;267(36):26134-41.
Cytokine modulation of elastin gene expression was examined by assay of elastin mRNA abundance and by transient transfections of cultured human skin fibroblasts and rat aortic smooth muscle cells with elastin promoter/reporter gene (chloramphenicol acetyltransferase, CAT) constructs. Incubation of cells with human recombinant tumor necrosis factor-alpha (TNF-alpha) markedly suppressed the elastin mRNA levels in a time- and dose-dependent manner by up to 91%. TNF-alpha also suppressed the expression of the elastin promoter/CAT construct by up to 70% in transiently transfected cells, indicating regulation at the transcriptional level. This suppression was temporally preceded by rapid and transient up-regulation of c-jun and c-fos genes. The down-regulatory effect of TNF-alpha on elastin promoter activity was abolished by co-transfections with a synthetic double-stranded AP-1 oligomer. Furthermore, co-transfection of the elastin promoter construct with c-jun and c-fos expression plasmids resulted in a marked decrease in the promoter activity. Elucidation of the cis-regulatory elements in the elastin promoter by 5' deletion construct analysis implicated a region -290 to -198 containing one AP-1 binding site. The functional role of this AP-1 site was further tested by gel retardation assays which indicated formation of a DNA-protein complex specific for TNF-alpha treated cells. This complex could be partially dissociated by a competing oligomer containing the consensus AP-1 binding site. These observations suggest that the inhibitory effects of TNF-alpha on elastin gene expression involve the transcription factor AP-1. Interferon-gamma also suppressed the elastin gene expression at the mRNA level by approximately 52%, but it had no effect on the elastin promoter activity, suggesting post-transcriptional mechanisms. These results indicate that mediators released from inflammatory cells can modulate elastin gene expression, and such modulation may play a role in diseases characterized by altered accumulation of elastic fibers in tissues.
通过检测弹性蛋白mRNA丰度以及用弹性蛋白启动子/报告基因(氯霉素乙酰转移酶,CAT)构建体对培养的人皮肤成纤维细胞和大鼠主动脉平滑肌细胞进行瞬时转染,研究了细胞因子对弹性蛋白基因表达的调节作用。用人重组肿瘤坏死因子-α(TNF-α)孵育细胞,以时间和剂量依赖的方式显著抑制弹性蛋白mRNA水平,最高可达91%。TNF-α还使瞬时转染细胞中弹性蛋白启动子/CAT构建体的表达降低了70%,表明在转录水平上受到调控。这种抑制在时间上先于c-jun和c-fos基因的快速短暂上调。TNF-α对弹性蛋白启动子活性的下调作用可通过与合成双链AP-1寡聚物共转染而消除。此外,将弹性蛋白启动子构建体与c-jun和c-fos表达质粒共转染导致启动子活性显著降低。通过5'缺失构建体分析阐明弹性蛋白启动子中的顺式调节元件,发现一个包含一个AP-1结合位点的-290至-198区域。通过凝胶阻滞试验进一步测试了该AP-1位点的功能作用,结果表明形成了一种对TNF-α处理细胞特异的DNA-蛋白质复合物。这种复合物可被含有共有AP-1结合位点的竞争寡聚物部分解离。这些观察结果表明,TNF-α对弹性蛋白基因表达的抑制作用涉及转录因子AP-1。干扰素-γ也在mRNA水平上抑制弹性蛋白基因表达约52%,但对弹性蛋白启动子活性无影响,提示其作用机制为转录后机制。这些结果表明,炎症细胞释放的介质可调节弹性蛋白基因表达,这种调节可能在以组织中弹性纤维积累改变为特征的疾病中起作用。